Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in children with hemangiomas and vascular malformations - Preliminary report

Pediatric Dermatology

Volumn 26, Issue 4, 2009, Pages 399-404

  Przewratil, Przemyslaw ^a   Sitkiewicz, Anna ^a   Wyka, Krystyna ^a   Andrzejewska, Ewa ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMANGIOMA; HUMAN; INFANT; INFANTILE HEMANGIOMA; MALE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROLIFERATING HEMANGIOMA; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEMANGIOMA; HUMANS; INFANT; MALE; OSMOLAR CONCENTRATION; SKIN NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR MALFORMATIONS;

EID: 68849084802     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2009.00910.x     Document Type: Article

References (23)

1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982 69 : 412 422.
2. Chang MW. Updated classification of hemangiomas and other vascular anomalies. Lymphat Res Biol 2003 1 : 259 265.
3. Smolinski KN, Yan AC. Hemangiomas of infancy: clinical and biological characteristics. Clin Pediatr (Phila) 2005 44 : 747 766.
4. Enjolras O, Wassef M, Chapot R. Color atlas of vascular tumors and vascular malformations. Cambridge : Cambridge University Press, 2007.
5. Greene AK, Fishman SJ. Angiogenesis and vascular anomalies. In : Oldham KT, ed. Principles and practice of pediatric surgery, Vol. 1. Philadelphia, PA : Lippincott Williams & Wilkins, 2005 : 535 548.
6. Frieden IJ, Haggstrom AN, Drolet BA et al. Infantile hemangiomas: current knowledge, future directions. Proceedings of a Research Workshop on Infantile Hemangiomas. April 7-9, 2005, Bethesda, Maryland. Pediatr Dermatol 2005 22 : 383 406.
7. Gupta K, Zhang J. Angiogenesis: a curse or cure? Postgrad Med J 2005 81 : 236 242.
8. Zhang Li, Xiaoxi Lin, Wei Wang et al. Circulating level of vascular endothelial growth factor in differentiating hemangioma from vascular malformation. Plast Reconstr Surg 2005 116 : 200 204.
9. Dosquet C, Coudert MC, Wassef M et al. Importance of bFGF for diagnosis and treatment of hemangioma. Ann Dermatol Venerol 1998 125 : 313 316. (in French)
10. Palgan I, Wysocki M, Szaflarska-Poplawska A et al. Evaluation of VEGF and bFGF serum levels with solid tumors - a preliminary report [in Polish]. Pol J Pediatr 2005 80 : 1096 1101.
11. Walsh DA. Pathophysiological mechanisms of angiogenesis. Adv Clin Chem 2007 44 : 187 221.
12. Frischer JS, Huang J, Serur A et al. Biomolecular markers and involution of hemangiomas. J Pediatr Surg 2004 39 : 400 404.
13. Tan ST, Velickovic M, Ruger BM et al. Cellular and extracellular markers of hemangioma. Plast Reconstr Surg 2000 106 : 529 538.
14. Blei F. Basic science and clinical aspects of vascular anomalies. Curr Opin Pediatr 2005 17 : 501 509.
15. Tille JC, Pepper MS. Hereditary vascular anomalies: new insight into their pathogenesis. Artherioscler Thromb Vasc Biol 2004 24 : 1578 1590.
16. Ribatti D. The crucial role of vascular permeability factor/vascular endothelial factor in angiogenesis: a historical review. Br J Haematol 2005 128 : 303 309.
17. Kleinman ME, Greives MR, Churgin SS. Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Arterioscler Thromb Vasc Biol 2007 27 : 2664 2670.
18. Zhang GY, Yi ChG, Li X et al. Proliferation hemangiomas formation through dual mechanism of vascular endothelial growth factor mediated endothelial progenitor cells proliferation and mobilization through matrix metlloproteinases 9. Med Hypotheses 2008 70 : 815 818.
19. 3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 1999 18 : 882 892.
20. Miller AM, Sandler AD. Elevated plasma vascular endothelial growth levels in 2 patients with hemangioendothelioma. J Pediatr Surg 2005 40 : E17 E19.
21. Barrientos S, Stojadinovic O, Golinko M et al. Growth factors and cytokines in wound healing. Wound Repair Regen 2008 16 : 585 601.
22. Marler JJ, Fishman SJ, Kilroy SM. Increased expression of urinary matrix metalloproteinases parallels extent and activity of vascular anomalies. Pediatrics 2005 116 : 38 45.
23. Gleizes PE, Noaillac Depeyre J, Amalric F et al. Basic fibroblast growth factor (FGF-2) internalization through the heparin sulfate proteoglycans- mediated pathway: an ultrastructural approach. Eur J Cell Biol 1995 66 : 47 59.